Morgan Stanley PE backed Omega Hospitals enters Bengaluru market by acquiring Cytecare Hospitals

image credit- shutterstock

Morgan Stanley PE backed Omega Hospitals has acquired Cytecare Hospitals, a leading cancer care hospital in Bengaluru. This strategic move marks Omega’s entry into a fast-growing micro-market in North Bengaluru.

Founded in 2016, Cytecare has built a strong reputation for clinical excellence, patient-centric care and research. It is a 150-bedded, NABH-accredited oncology centre strategically located on the international airport road in Bengaluru’s fast-growing Northern corridor.

Speaking on this occasion, Dr Mohana Vamsy, Managing Director of Omega Hospitals said, “This acquisition is a significant milestone for Omega, providing an entry in an important geography we want to focus outside our core geographies of AP & Telangana. Over the last 2 years we have been working on creating pan-India centres of excellence and our recent foray in Jabalpur, Surat, Vijaywada, Tirupati and now Bengaluru is part of the same expansion strategy. We hope to deliver on our commitment to provide advanced and high-quality care for cancer patients.”

Sharing his thoughts on the acquisition, Executive Director at Morgan Stanley PE, Prateek Bhurat said, “We have been in touch with Dr Ferzaan and team for the past year and very pleased that the deal has concluded. We recognise that Cytecare is strategically located, has good clinical talent and has tremendous potential for future growth. This unit will be developed as Omega’s centre of excellence for quaternary cancer care with investment earmarked for top clinical talent and high-end medical equipment.”

Morgan Stanley PE had invested ~Rs 500 crore in Omega last year in June 2024. Omega has been expanding its cancer care presence pan-India by entering markets like Jabalpur, Tirupati, Surat, Vijayawada and Yamuna Nagar. It currently operates 14 hospitals with a total capacity of ~2,000 beds across 5 states. Omega has also bolstered its operational capabilities by bringing in Dr Vijay Vemuri with considerable operating experience at AOI as Executive Director.